ADMA Biologics, Inc.Company Review & Valuation

ADMA
Nasdaq
Latest Price
2.09USD
Market Capitalization
180.47mUSD

About ADMA Biologics, Inc.

ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases. Its lead product candidate is RI-002 derived from human plasma, which has completed Phase III clinical trials foShow more r the treatment of primary immune deficiency disease. The company also operates source plasma collection facilities in Norcross and Marietta, Georgia. In Addition, the company offers Nabi-HB for the treatment of acute exposure; and Bivigam for the treatment of primary humoral immunodeficiency. It distributes its products through independent distributors, sales agents, specialty pharmacies, and others. The ADMA Biologics, Inc. was founded in 2004 and is headquartered in Ramsey, New Jersey. Show less

Industry
Biotechnology
HQ Location
Ramsey, New Jersey

Stock Price

Price data not available for ADMA Biologics, Inc..

Performance

Please login or create a free account to view the contents of this section.

Similar Companies

back to top